A non-thermal electrospraying technology that produces sub-micron particles to encapsulate bioactives, vitamins, and botanicals with up to 90% efficiency. The technology improves shelf life by up to 6 months, retains natural colours and flavours, and reduces energy use by up to 20% compared to spray-drying. Ideal for food, beverage, and nutraceutical manufacturers seeking improved ingredient stability.
This solution leverages electrospraying, an emerging non-thermal particle production technology, to create sub-micron encapsulant particles that protect sensitive food ingredients. The technology addresses key challenges in the food and nutraceutical industries by enhancing the encapsulation efficiency of bioactives, vitamins, and botanicals, while preserving the colour of natural colorants. By eliminating the need for heat during processing, the technology achieves higher retention of colourings, vitamins, and flavours compared to conventional methods. Additionally, electrospraying requires up to 20% less energy than spray-drying, offering both quality and sustainability benefits.
Key features:
The technology has been experimentally validated, with demonstrated encapsulation efficiencies of up to 90% and confirmed stability of encapsulants under various pH, temperature, and humidity conditions. Ongoing and future work aims to extend shelf life to up to 1 year by tailoring carrier materials, and to validate performance when particles are incorporated into beverages. Further validation will assess thermal degradation and encapsulation efficiency across diverse storage conditions, advancing the technology toward broader commercial application.
The University of Leeds is a comprehensive, research‑intensive public university serving a large student body and global partner network. Industry partners engage through an on‑campus innovation hub offering flexible workspace, shared labs and prototyping, and options to co‑locate with academic experts. The university’s integration with major NHS teaching hospitals in the city enables clinical research, validation, and translation. Research is backed by competitive funding from UK Research and Innovation (UKRI) councils and the National Institute for Health and Care Research, with additional European and industry support. A dedicated technology transfer office manages IP, licensing, and spinouts, with partnership models and professional education tailored for corporate R&D.